鼠源(同基因型)肿瘤模型

癌症免疫治疗在近年已经成为癌症研究领域的主要焦点,也因其特殊的疗效被认为是将“治疗癌症”转变为“治愈癌症”的希望所在。鼠源(同基因型)肿瘤模型使用免疫正常的小鼠作为肿瘤研究的载体,使得对肿瘤免疫治疗的药效评估成为可能。金斯瑞有经验丰富的团队为您提供多种鼠源肿瘤模型上的癌症免疫治疗疗效评估服务,例如针对免疫检查点的抑制性抗体以及肿瘤疫苗等的研究服务。


  • Case Study 1
  • Case Study 2

Mouse syngeneic tumor models

Figure 1: Anti-mPD-1 and anti-mCTLA-4 antibodies inhibit the growth of MC38 s.c. model as monotherapy or in combination.

Figure 2: Anti-mPD-1 and anti-mCTLA-4 antibodies inhibit the growth of CT26 s.c. model as monotherapy or in combination.


Validation of hPD-1 KI Mice and hCTLA-4 KI mice with MC38 Tumor Model

Figure 1: Anti-hPD-1 antibody (Keytruda) inhibits the growth of MC38 s.c. model

Validation of hPD-1 KI Mice and hCTLA-4 KI mice with MC38 Tumor Model

Figure 2: Anti-hCTLA-4 antibody (Yervoy biosimilar) inhibits the growth of MC38 s.c. model

询价与订购

为了能够准确高效地为您提供报价,请您首先下载并完整服务询价表,然后将填写完整的询价表通过邮件发给我们,我们将第一时间为您提供报价。

客服